HUP0303154A3 - New crystal forms of oxcarbazepine and processes for their preparation - Google Patents

New crystal forms of oxcarbazepine and processes for their preparation

Info

Publication number
HUP0303154A3
HUP0303154A3 HU0303154A HUP0303154A HUP0303154A3 HU P0303154 A3 HUP0303154 A3 HU P0303154A3 HU 0303154 A HU0303154 A HU 0303154A HU P0303154 A HUP0303154 A HU P0303154A HU P0303154 A3 HUP0303154 A3 HU P0303154A3
Authority
HU
Hungary
Prior art keywords
oxcarbazepine
processes
preparation
crystal forms
new crystal
Prior art date
Application number
HU0303154A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HUP0303154A2 publication Critical patent/HUP0303154A2/hu
Publication of HUP0303154A3 publication Critical patent/HUP0303154A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HU0303154A 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation HUP0303154A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12
PCT/US2002/004065 WO2002064557A2 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Publications (2)

Publication Number Publication Date
HUP0303154A2 HUP0303154A2 (hu) 2004-01-28
HUP0303154A3 true HUP0303154A3 (en) 2009-08-28

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303154A HUP0303154A3 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Country Status (11)

Country Link
US (1) US7183272B2 (hu)
EP (1) EP1368322A4 (hu)
JP (1) JP2004526706A (hu)
AU (1) AU2002250057A1 (hu)
CA (1) CA2437402A1 (hu)
DE (1) DE02718948T1 (hu)
ES (1) ES2211373T1 (hu)
HU (1) HUP0303154A3 (hu)
IL (1) IL157351A0 (hu)
TR (1) TR200400313T3 (hu)
WO (1) WO2002064557A2 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106414A2 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
JP2009516655A (ja) * 2005-11-22 2009-04-23 テバ ファーマシューティカル インダストリーズ リミティド シナカルセット塩酸塩の結晶形フォーム（Ｆｏｒｍ）、およびそれらの調製方法
PL2004646T3 (pl) 2006-04-05 2016-12-30 Chlorowodorek 8-[{l-(3,5-bis(trifluorometylo)fenylo)-etoksy}-metylol-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu i sposób jego otrzymywania
CN101489560B (zh) 2006-04-26 2015-11-25 苏佩努斯制药公司 具有s形释放曲线的奥卡西平控释制剂
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
JP5860399B2 (ja) * 2009-08-14 2016-02-16 オプコ ヘルス， インコーポレイテッド ニューロキニン−１アンタゴニストの静脈内用製剤
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
CA3224977A1 (en) 2018-09-28 2020-04-02 Griffith University Agents and methods for modulating pathogen activity using ligands of complement receptor 3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
WO2003106414A2 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide

Also Published As

Publication number Publication date
US7183272B2 (en) 2007-02-27
EP1368322A4 (en) 2004-03-17
EP1368322A2 (en) 2003-12-10
ES2211373T1 (es) 2004-07-16
IL157351A0 (en) 2004-02-19
HUP0303154A2 (hu) 2004-01-28
TR200400313T3 (tr) 2004-04-21
WO2002064557A9 (en) 2002-11-28
WO2002064557A2 (en) 2002-08-22
CA2437402A1 (en) 2002-08-22
AU2002250057A1 (en) 2002-08-28
US20030004154A1 (en) 2003-01-02
JP2004526706A (ja) 2004-09-02
DE02718948T1 (de) 2004-07-08
WO2002064557A3 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
SG107123A1 (en) Display and method of manufacturing the same
IL158591A0 (en) Crystal forms of azithromycin
AU2002364528A8 (en) Bio-implant and method of making the same
GB0124299D0 (en) Crystal structure of enzyme and uses thereof
GB0112699D0 (en) Process for the preparation of prostglandins and analogues thereof
EP1405856A4 (en) OLIGOSACCHARIDE CRYSTALS AND METHODS FOR PREPARING THE SAME
HRP20040077A2 (en) Crystalline forms vi and vii of atorvastatin-calcium
HUP0303154A3 (en) New crystal forms of oxcarbazepine and processes for their preparation
SG119165A1 (en) Display apparatus and method of manufacturing the same
HUP0400296A3 (en) Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
IL157608A0 (en) New crystal forms of lamotrigine and processes for their preparations
IL159266A0 (en) Crystalline forms of fexofenadine and processes for the preparation thereof
PL373845A1 (en) Crystal forms of olanzapine and processes for their preparation
SG108260A1 (en) Flat panel display and method of manufacture
AU2002322445A1 (en) Crystals and structures of arnb aminotransferases
HUP0400869A3 (en) Novel crystal forms of phenylethenesulfonamide pyrimidin derivative and process for producing the same
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
AU2002348942A8 (en) Process for the preparation of tofisopam and new intermediates
AU2002360409A8 (en) Methods and intermediates for the synthesis of azepines
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
AU2002340437A1 (en) Crystals and structures of yiim proteins
EP1435953A4 (en) ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
GB0108287D0 (en) Methods of crystal optimisation
AU2002365245A8 (en) Crystal structure of yqej and uses thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees